Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenrong Anshen Pill is a traditional Chinese medicine (TCM) formulation produced by Liaoyuan Yulong Yadong Pharmaceutical. It is primarily indicated for the treatment of neurasthenia, insomnia, forgetfulness, and palpitations, particularly those arising from a deficiency of both the heart and spleen or insufficiency of qi and blood. The formulation typically includes tonic ingredients such as ginseng (Shen) and pilose antler (Rong), which are traditionally used to nourish the heart, soothe the nerves, and replenish vital energy. As a multi-herb TCM product, its therapeutic effects are attributed to the synergistic actions of its various botanical and animal-derived components. The manufacturer, Liaoyuan Yulong Yadong Pharmaceutical, was acquired by Xinmingyuan Pharmaceutical in 2023.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenrong Anshen Pill.